KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Cash from Financing Activities: 2009-2024

Historic Cash from Financing Activities for Encompass Health (EHC) over the last 16 years, with FY2024 value amounting to -$330.6 million.

  • Encompass Health's Cash from Financing Activities fell 2648.04% to -$113.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$464.2 million, marking a year-over-year decrease of 11071.27%. This contributed to the annual value of -$330.6 million for FY2024, which is 6764.71% down from last year.
  • Latest data reveals that Encompass Health reported Cash from Financing Activities of -$330.6 million as of FY2024, which was down 6764.71% from -$197.2 million recorded in FY2023.
  • In the past 5 years, Encompass Health's Cash from Financing Activities registered a high of -$145.7 million during FY2022, and its lowest value of -$330.6 million during FY2024.
  • Its 5-year average for Cash from Financing Activities is -$211.9 million, with a median of -$197.2 million in 2023.
  • In the last 5 years, Encompass Health's Cash from Financing Activities tumbled by 40269.71% in 2020 and then skyrocketed by 3931.7% in 2022.
  • Encompass Health's Cash from Financing Activities (Annual) stood at -$145.9 million in 2020, then crashed by 64.56% to -$240.1 million in 2021, then soared by 39.32% to -$145.7 million in 2022, then tumbled by 35.35% to -$197.2 million in 2023, then crashed by 67.65% to -$330.6 million in 2024.
  • Its last three reported values are -$330.6 million in FY2024, -$197.2 million for FY2023, and -$145.7 million during FY2022.